West Pharmaceutical Services, Inc. (WST) Stock Analysis

West Pharmaceutical Services, Inc. (WST) Stock Analysis — AI Research | MarketCI

WST

Market Closed

West Pharmaceutical Services, Inc.

NYSEHealthcare Medical - Instruments & Supplies

10.60K employees

CEO: Eric Green

Founded: 1980

$328.03

+$0.00(+NaN%)

Market Cap

23.17B

Beta

1.18

52W Range

N/A

Dividend Yield

0.27%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

WST Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for WST built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$93.05

AI Price Target

Machine learning • Price prediction

$289.58

Market Sentiment

News & social media analysis

0.02

Value Investor Price

Classic value analysis

$42.44

Financial Health

Bankruptcy risk assessment

15.39

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting WST investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

59.52% Good

Conditions Met

25.00/42.00

Due Diligence Score

59.52%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions